Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parry, G. J.
Right arrow Articles by Kohzu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parry, G. J.
Right arrow Articles by Kohzu, H.
NEUROLOGY 1990;40:107
© 1990 American Academy of Neurology

Acute changes in blood glucose affect resistance to ischemic nerve conduction failure

Gareth J. Parry, MB, FRACP and Hitoshi Kohzu, MD

LSU School of Medicine, New Orleans, LA.

We studied resistance to ischemic nerve conduction failure (RINCF) following rapid alterations of blood glucose in normal and diabetic rats. We measured RINCF hourly for 4 hours in normal and diabetic rats. We then made normal rats hyperglycemic and diabetics euglycemic. In normal rats, we measured RINCF sequentially for 4 hours immediately after glucose injection and once after 1,2,3, or 4 hours of hyperglycemia. In diabetics, we measured RINCF sequentially for 4 hours after insulin injection. In normal rats, in sequential measurements, RINCF progressively fell but glucose injection prevented this fall. Hyperglycemia without preceding ischemia increased RINCF. In diabetic rats, sequential measurements also produced a decline in RINCF, accentuated with insulin injection. The results suggest that both glucose and insulin are important in determining the response of peripheral nerve to ischemia. They also underscore the importance of knowing the blood glucose and time of most recent insulin injection when measuring RINCF.

Address correspondence and reprint requests to Dr. Gareth J. Parry, LSU School of Medicine, Department of Neurology, 1542 Tulane Avenue, New Orleans, LA 70112

Supported by grants from the Juvenile Diabetes Foundation International and the American Medical Association–Education and Research Foundation.

Received March 8, 1989. Accepted for publication in final form June 27, 1989.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
P. MAYER, M. DEMATTEIS, J. L. PÉPIN, B. WUYAM, D. VEALE, A. VILA, and P. LÉVY
Peripheral Neuropathy in Sleep Apnea . A Tissue Marker of the Severity of Nocturnal Desaturation
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 213 - 219.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.